Skip to Content
Get involved: The PAPAA Blog
Welcome to:

The PAPAA Blog

This is a discussion area for anyone with an interest in psoriasis and psoriatic arthritis.

Only registered website members can create a reply. All replies are subject to moderation. 

Please be aware that some of these blogs are personal opinions and views, and may not be the views of PAPAA.

We also have an HCP only blog.

Software and apps advice

Advice for members of the public and professional users of software and apps used in COVID-19 pandemic has been published by the MHRA.

How to tell if an app is a medical device

If the software or app you are using has a medical purpose it is important that it is CE marked.

A CE mark is a logo that is placed on medical devices to show they…

Reassurance to patients on immunosuppressive medications

Data on the course of COVID-19 in patients with rheumatic conditions are still rare and limited to small numbers of cases. Patients with rheumatic diseases are concerned about the extent to which their condition increases the risk of a severe course and the impact of the intake of their immunosuppressants on this.

"There is considerable…

New shielding guidance

The government has updated its guidance for people who are shielding taking into account that COVID-19 disease levels are substantially lower now than when shielding was first introduced.

People who are shielding remain vulnerable and should continue to take precautions but can now leave their home if they wish, as long as they are able to…

Back to work guidance

Following the announcement issued about the next steps to help people return to work, guidance in now available. Although there is different advice from all four nations, the Department for Business, Energy & Industrial Strategy has issued the following material.

The guidance is to help employers, employees and the self-employed understand…

Show More